In this session, we brought together three experts to share on the latest developments of new point-of-care diagnostic platform technologies, regulatory requirements and the future of the diagnostic market, as well as how the company, MiRXES responded to the urgent need of COVID-19 diagnostic tests and its journey in commercialising the diagnostic kits worldwide.